Mandating providers to have epi pens on hand for students with undiagnosed allergies is a bad idea for a variety of reasons.

First, the burden on providers to diagnose anaphylactic reactions in non allergy students. There could be misdiagnosis, leading to unnecessary administration. 

Second, the cost of maintaining a variety of dosages and the upkeep required as epi pens have a short shelf life. Epi pens cost $650-$800 dollars for a two pack. Having to store just two different dosages would be a very high initial cost as well as replacements.

Third, the liability that providers would incur for providing medications to students without prescriptions nor written permission from parents. This is a significant liability for providers.

There are not enough pros to outweigh the cons for this law, especially one that is fast tracked.